Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s share price gapped down prior to trading on Wednesday . The stock had previously closed at $4.5330, but opened at $4.36. Curaleaf shares last traded at $4.93, with a volume of 593,187 shares traded.
Wall Street Analyst Weigh In
CURLF has been the subject of several research analyst reports. Atb Cap Markets upgraded Curaleaf from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, December 2nd. ATB Capital raised Curaleaf to an "outperform" rating in a research note on Tuesday, December 2nd. Finally, Canaccord Genuity Group upgraded Curaleaf to a "strong-buy" rating in a report on Thursday, October 9th. Two analysts have rated the stock with a Strong Buy rating and one has given a Buy rating to the company. Based on data from MarketBeat, Curaleaf presently has an average rating of "Strong Buy".
Get Our Latest Research Report on CURLF
Curaleaf Price Performance
The company has a current ratio of 1.47, a quick ratio of 0.71 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $3.21 billion, a P/E ratio of -14.78 and a beta of 0.77. The company has a 50 day moving average price of $2.73 and a 200 day moving average price of $2.18.
Curaleaf (OTCMKTS:CURLF - Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative return on equity of 15.57% and a negative net margin of 19.50%. On average, equities analysts predict that Curaleaf Holdings, Inc. will post -0.25 EPS for the current fiscal year.
Curaleaf Company Profile
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.